Atezolizumab Plus Bevacizumab in Advanced HCC: Efficacy in NASH-Specific Etiology

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Access to Document

@article{6ef00e37b49941daab9c20587fc61296,

title = "Atezolizumab Plus Bevacizumab in Advanced HCC: Efficacy in NASH-Specific Etiology",

author = "Llovet, {Josep M.} and Mathias Heikenwalder",

year = "2023",

month = nov,

doi = "10.1053/j.gastro.2023.04.014",

language = "English",

volume = "165",

pages = "1308--1310",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders",

number = "5",

}

TY - JOUR

T1 - Atezolizumab Plus Bevacizumab in Advanced HCC

T2 - Efficacy in NASH-Specific Etiology

AU - Llovet, Josep M.

AU - Heikenwalder, Mathias

PY - 2023/11

Y1 - 2023/11

UR - http://www.scopus.com/inward/record.url?scp=85173967000&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2023.04.014

DO - 10.1053/j.gastro.2023.04.014

M3 - Letter

C2 - 37116832

AN - SCOPUS:85173967000

SN - 0016-5085

VL - 165

SP - 1308

EP - 1310

JO - Gastroenterology

JF - Gastroenterology

IS - 5

ER -